https://doi.org/10.1016/s0140-6736(17)32130-x
B
Benjamin M. Althouse
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
162
Papers
8.5K
Citations
46
h-index
94
i10-index
Benjamin M. Althouse is an academic researcher from Pfizer (United States). The author has contributed to research in topics: COVID-19 epidemiological studies & Data-Driven Disease Surveillance & Influenza Virus Research Studies. The author has an h-index of 46, co-authored 138 publications.
ORCID: 0000-0002-5464-654XPapers by this author
worksGlobal, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
2017 · The Lancet · 2,129 citations
Asymptomatic transmission and the resurgence of Bordetella pertussis
2015 · BMC Medicine · 265 citations
https://doi.org/10.1186/s12916-015-0382-8
Role of monkeys in the sylvatic cycle of chikungunya virus in Senegal
2018 · Nature Communications · 83 citations
https://doi.org/10.1038/s41467-018-03332-7
Impact of SARS-CoV-2 Gamma lineage introduction and COVID-19 vaccination on the epidemiological landscape of a Brazilian city
2022 · Communications Medicine · 59 citations
https://doi.org/10.1038/s43856-022-00108-5
A Novel Evaluation of World No Tobacco Day in Latin America
2012 · Journal of Medical Internet Research · 56 citations
https://doi.org/10.2196/jmir.2148
Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities
2023 · Vaccine · 44 citations
https://doi.org/10.1016/j.vaccine.2023.02.038
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat